Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …
Feature

Contract research news in brief

October 31, 2011 Manufacturing and Production, Research and Development CRO, manufacturing and production

PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …
News
Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011 Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …
News
NICE building

Mepact wins NICE backing

October 26, 2011 Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …
News
Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011 Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …
News

David Meeker appointed as chief executive of Genzyme

October 25, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Appointment

New venture a ‘game-changer’ for pharma

October 25, 2011 Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …
News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011 Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …
News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …
News
Press release
Lab image

Does drug development deliver on its promises?

October 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …
Feature
Merck image

Merck to invest $1billion in Singapore R&D and manufacturing

October 24, 2011 Manufacturing and Production, Research and Development

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …
News

Bristol-Myers Squibb makes three senior management changes

October 24, 2011 Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …
Appointment
Depakote

Abbott to pay $1.3 billion for Depakote lawsuits

October 24, 2011 Research and Development, Sales and Marketing Abbott, Depakote

 
News

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011 Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …
News

Abbott spin-off could attract mega merger

October 21, 2011 Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026